日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Optimal Adjuvant Therapy Selection for Chinese BRAF V600-Mutant Stage III Melanoma: A Multicenter Efficacy Comparison of Targeted Agents, Immunotherapy, and Combinatorial Strategies

中国BRAF V600突变型III期黑色素瘤最佳辅助治疗方案选择:靶向药物、免疫疗法和联合治疗策略的多中心疗效比较

Zhang, Rongcheng; Liang, Yao; Li, Jingjing; Chen, Qianqi; Ding, Ya; Wen, Xizhi; Zhao, Baiwei; Zheng, Wei; Wu, Junwan; Zhang, Qiong; Chen, Ziluan; Ding, Qiuyue; Chen, Linbin; Li, Renai; Li, Ke; Zhou, Qiming; Zhang, Xiaoshi; Li, Dandan

Acidic Site Regulation of the Supported Pt-Cu Alumina Catalyst with the Bimetallic Synergistic Effect Achieved High Catalytic Selectivity in Dehydrogenation of Perhydrodibenzyltoluene

通过双金属协同效应调控负载型Pt-Cu氧化铝催化剂的酸性位点,实现了对全氢二苄基甲苯脱氢反应的高催化选择性

Ding, Qiuyue; Li, Qing; Wei, Huijie; Zhang, Yixuan; Xi, Yanyan; Hu, Songqing; Lin, Xufeng

Combination of Postoperative Adjuvant Chemoradiotherapy and Immune Checkpoint Inhibitors Significantly Prolongs Recurrence-Free Survival in Sinonasal Mucosal Melanoma

术后辅助放化疗联合免疫检查点抑制剂可显著延长鼻窦黏膜黑色素瘤患者的无复发生存期

Ding, Qiuyue; Wu, Junwan; Ding, Ya; Li, Dandan; Wen, Xizhi; Jiang, Hang; Chen, Linbin; Zhang, Qiong; Zhang, Yuan; Lu, Lixia; Zhang, Xiaoshi; Li, Jingjing

Addition of anti-PD-1 immunotherapy to BRAF inhibitor-based targeted therapy improves real-world survival and delays brain metastases in patients with BRAF(V600)-mutant advanced melanoma: a multicenter cohort study

在BRAF抑制剂靶向治疗的基础上加用抗PD-1免疫疗法可改善BRAF(V600)突变型晚期黑色素瘤患者的真实世界生存期并延缓脑转移:一项多中心队列研究

Wu, Junwan; Ding, Qiuyue; Zhang, Qiong; Chen, Qianqi; Wen, Xizhi; Ding, Ya; Li, Jingjing; Chen, Ziluan; Zhang, Tao; Wang, Jiuhong; Huang, Fuxue; Jiang, Hang; Chen, Linbin; Zhou, Qiming; Li, Ke; Zhang, Xiaoshi; Li, Dandan

pH-responsive hydrogel system loaded with curcumin-preconditioned mesenchymal stem cell exosomes for enhanced diabetic wound healing in orthopedic applications

一种负载姜黄素预处理的间充质干细胞外泌体的pH响应型水凝胶系统,用于增强骨科应用中的糖尿病伤口愈合。

Li, Senlei; Li, Yangyang; Chen, Yazhou; Guo, Jiawen; Zou, Qian; Ding, Qiuyue

Natural Killer Cell Activation Signature Identifies Cyclin B1/CDK1 as a Druggable Target to Overcome Natural Killer Cell Dysfunction and Tumor Invasiveness in Melanoma.

自然杀伤细胞激活特征表明细胞周期蛋白 B1/CDK1 可作为药物靶点,以克服黑色素瘤中自然杀伤细胞功能障碍和肿瘤侵袭性

Chen Linbin, Liao Wanqian, Huang Jing, Ding Qiuyue, Wu Junwan, Zhang Qiong, Ding Ya, Li Dandan, Li Jingjing, Wen Xizhi, Zhang Xiaoshi

Alumina-supported highly dispersed platinum-copper nanocatalyst with good dehydrogenation performance for perhydromonobenzyltoluene as a hydrogen carrier

以氧化铝为载体的高分散铂铜纳米催化剂,对全氢单苄基甲苯作为氢载体具有良好的脱氢性能。

Ding, Qiuyue; Zhang, Yixuan; Wei, Huijie; Li, Qing; Xi, Yanyan; Hu, Songqing; Lin, Xufeng

Roles of heat shock protein A12A in the development of diabetic cardiomyopathy

热休克蛋白A12A在糖尿病心肌病发生发展中的作用

Yunxiao Jia, Yunhao Yu, Chenxi Gao, Yuehua Li, Chuanfu Li, Zhengnian Ding, Qiuyue Kong, Li Liu

Understanding the Effect of Grain Boundaries on the Mechanical Properties of Epoxy/Graphene Composites

了解晶界对环氧树脂/石墨烯复合材料力学性能的影响

Ding, Qiuyue; Ding, Ning; Chen, Xiangfeng; Guo, Wenyue; Zaïri, Fahmi

Clinical features and response to systemic therapy in NRAS-mutant Chinese melanoma patients

NRAS突变型中国黑色素瘤患者的临床特征及对全身治疗的反应

Wang, Jiuhong; Jiang, Hang; Huang, Fuxue; Li, Dandan; Wen, Xizhi; Ding, Qiuyue; Ding, Ya; Zhang, Xiaoshi; Li, Jingjing